← Back to Search

Predictive Analytics and Peer-Driven Intervention for Guideline-based Care for Sleep Apnea

N/A
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30, day 90, and day 180
Awards & highlights
No Placebo-Only Group

Summary

Obstructive sleep apnea (OSA) is a prevalent condition that affects 7 to 12% of the US population and is characterized by repetitive collapse of the upper airway during sleep. Continuous positive airway pressure (CPAP) has been shown to be highly effective in the treatment of OSA, however, adherence is poor with up to 54% of patients being non-adherent to CPAP therapy by Medicare criteria, which has been attributed to inadequate patient education and support for CPAP therapy. Poor treatment adherence in patients with OSA can lead to adverse health consequences, poor quality of life, and patient dissatisfaction. Poor treatment adherence may be due to lack of sufficient patient education, time delays in delivery of care, lack of adequate healthcare coordination, or difficulty accessing various healthcare providers across a front desk which serves as a "healthcare bottle-neck". Better efficiency in healthcare delivery, with greater connectivity through knowledgeable and trained peer volunteers and cheap cell-phones integrated by a smart telephone exchange may alleviate some of the care and communication burden faced by the healthcare system. Specifically, such community health education volunteers ("peer-buddies") who are experienced in managing their OSA may be able to impart knowledge and confidence to a recently diagnosed patient in a much more personalized manner than that of a group therapy session.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 90, and day 180
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 90, and day 180 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of patients undergoing sleep study testing
Secondary study objectives
CPAP Adherence downloads
Other study objectives
Body Mass Index (BMI)
Diastolic blood pressure
Epworth Sleepiness Scale
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer-buddy systemExperimental Treatment1 Intervention
Will meet with peer-buddy who will help with them with CPAP usage. Also will receive standard of care CPAP educational training
Group II: Usual CareActive Control1 Intervention
Will receive educational material at the same frequency that those in the experimental arm. Will also receive standard of care CPAP educational training.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
539 Previous Clinical Trials
161,030 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,944 Previous Clinical Trials
47,799,687 Total Patients Enrolled
~18 spots leftby Jan 2026